Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing by Erik J. Landaas MPH, Ashley M. Eckel MD, PhD, Jonathan L. Wright MD, Geoffrey S. Baird MD, PhD, Ryan N. Hansen PhD, PharmD, Sean D. Sullivan PhD

Get full text

A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy by Matthew D. Greer, MD, Stephanie K. Schaub, MD, Stephen R. Bowen, PhD, Jay J. Liao, MD, Kenneth Russell, MD, Jonathan J. Chen, MD, Emily S. Weg, MD, Juergen Meyer, PhD, Tristan Alving, George R. Schade, MD, John L. Gore, MD, Sarah P. Psutka, MD, MS, Robert B. Montgomery, MD, Michael Schweizer, MD, Evan Y. Yu, MD, Petros Grivas, MD, PhD, Jonathan L. Wright, MD, MS, FACS, Jing Zeng, MD

Get full text